TP53 and neoplasm: Notably, mutations or overexpression of genes, such as EGFR, p53, PIK3CA, and Cyclin D1 are frequently observed in HNSCC, closely correlating with tumor aggressiveness and patient prognosis [11, 12, 13, 14].